SAN DIEGO, Calif. and ST. OUEN L’AUMONE, France — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced that Laboratoire Cerba has launched its validated noninvasive prenatal test (NIPT) to health care providers and their patients in France, Belgium, Luxembourg and portions of the Middle East and Africa. […]

The Board of Directors of SomaLogic Inc. (a privately held biotechnology company) announced today that Byron Hewett has been appointed as Chief Executive Officer (CEO), effective Dec 2, 2013. SomaLogic was founded in 2000 by its original CEO, Larry Gold, who will continue as Chairman of the Board. Dr. Gold will also continue to work […]

Maryville, TN — Molecular Pathology Laboratory Network, Inc. (MPLN) announced today that it has acquired the Illumina MiSeqDx™, currently the only next generation sequencing system approved by the US Food and Drug Administration (FDA). MPLN will be the first laboratory in the country to own the FDA approved version of this revolutionary technology, and will […]

Niel – Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing (MPS), today announces that it is launching a CE/IVD labeled MID kit for Illumina® MiSeq® together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity […]

Mechelen (Belgium)/Lausanne (Switzerland)– Biocartis announced that bioMérieux and Biocartis have signed an agreement to end their alliance for the development and commercialization of the integrated molecular biology system, IdyllaTM (previously Apollo), in the field of microbiology molecular diagnostics. bioMérieux will return all rights on the IdyllaTM platform to Biocartis. In November 2010, Biocartis had entered […]

BILLERICA, Mass. — Bruker Corporation (NASDAQ: BRKR) today announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens. The MALDI Biotyper CA System includes the bench-top microflex™ MALDI-TOF (matrix-assisted laser […]

FRAMINGHAM, Mass. — Continuing to rapidly expand its presence in the clinical diagnostics field, AB SCIEX, a global leader in analytical technologies, today announced the launch of its AB SCIEX IVD-MS™ Analyzer CE marked for general in vitro diagnostic use in Europe.* The release of this mass spectrometry-based analyzer is in response to growing demand […]

SOUTH SAN FRANCISCO, Calif. — Fluxion Biosciences, Inc. announced the presentation of the first pilot study results aimed at isolating circulating tumor cells (CTCs) from early stage non-small cell lung cancer (NSCLC) patients obtained in collaboration with Dr. Max Diehn’s lab at Stanford University. CTCs are cells that disseminate from primary tumors and contribute to […]

BETHLEHEM, Pa. –– OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that it has reached an agreement with Thermo Fisher Scientific (Thermo Fisher), to develop and supply up to 12 homogenous fully automated oral fluid drugs of abuse assays to be used with a new Intercept® oral fluid specimen collection device. OraSure will have the right to […]

In response to the FDA News Release “FDA Allows Marketing of Four ‘Next Generation’ Gene Sequencing Devices,” RainDance Technologies issued the following statement today: “The first FDA clearance of a Next-Generation DNA Sequencing System is a significant milestone for the genomics industry and a strong validation of the recent advances in technology performance and data […]